risedronic acid has been researched along with Muscular Atrophy, Postpoliomyelitis in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, A | 1 |
| Kremer, R | 1 |
| Weiss, DR | 1 |
| Benedetti, A | 1 |
| Haziza, M | 1 |
| Trojan, DA | 1 |
1 other study available for risedronic acid and Muscular Atrophy, Postpoliomyelitis
| Article | Year |
|---|---|
Response of postpoliomyelitis patients to bisphosphonate treatment.
Topics: Administration, Oral; Alendronate; Bone Density; Bone Density Conservation Agents; Case-Control Stud | 2010 |